Citizens Maintains Market Outperform on US Physical Therapy, Lowers Price Target to $98

Benzinga Newsdesk www.benzinga.com Negative 89.8%

Neg 89.8% Neu 0% Pos 0%

Citizens analyst Constantine Davides maintains US Physical Therapy (NYSE:USPH) with a Market Outperform and lowers the price target from $113 to $98.